Li Kang Biomedical Co., Ltd. (6242.TWO)
- Previous Close
41.95 - Open
41.95 - Bid 41.60 x --
- Ask 42.00 x --
- Day's Range
41.60 - 42.25 - 52 Week Range
35.20 - 52.60 - Volume
7,208 - Avg. Volume
19,615 - Market Cap (intraday)
1.334B - Beta (5Y Monthly) -0.02
- PE Ratio (TTM)
16.71 - EPS (TTM)
2.51 - Earnings Date --
- Forward Dividend & Yield 2.50 (6.13%)
- Ex-Dividend Date Jun 20, 2024
- 1y Target Est
--
Li Kang Biomedical Co., Ltd. manufactures and sells supplement, cosmeceutical, and hygienic drink products. It also engages in the management and consulting of tourism factory business; and offers telemarketing services. The company was formerly known as BAFO Technologies Corporation and changed its name to Li Kang Biomedical Co., Ltd. in September 2014. Li Kang Biomedical Co., Ltd. was founded in 1982 and is based in Tainan City, Taiwan.
www.likangbio.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 6242.TWO
View MorePerformance Overview: 6242.TWO
Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6242.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6242.TWO
View MoreValuation Measures
Market Cap
1.33B
Enterprise Value
985.82M
Trailing P/E
16.98
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.31
Price/Book (mrq)
1.56
Enterprise Value/Revenue
1.74
Enterprise Value/EBITDA
8.78
Financial Highlights
Profitability and Income Statement
Profit Margin
13.62%
Return on Assets (ttm)
6.04%
Return on Equity (ttm)
10.37%
Revenue (ttm)
565.52M
Net Income Avi to Common (ttm)
77.02M
Diluted EPS (ttm)
2.51
Balance Sheet and Cash Flow
Total Cash (mrq)
454.4M
Total Debt/Equity (mrq)
10.74%
Levered Free Cash Flow (ttm)
-13.73M